Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3461 | 1069 | 40.1 | 84% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
213 | 47427 | PROSTATE CANCER//PROSTATIC NEOPLASMS//RADICAL PROSTATECTOMY |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
11740 | 894 | CLUSTERIN//APOLIPOPROTEIN J//CLUSTERIN APOLIPOPROTEIN J |
28075 | 175 | ELASTOFIBROMA//ELASTOFIBROMA DORSI//PERISCAPULAR MASS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CLUSTERIN | Author keyword | 288 | 60% | 29% | 311 |
2 | ELASTOFIBROMA | Author keyword | 114 | 88% | 5% | 53 |
3 | ELASTOFIBROMA DORSI | Author keyword | 59 | 90% | 2% | 26 |
4 | APOLIPOPROTEIN J | Author keyword | 28 | 53% | 3% | 37 |
5 | CLUSTERIN APOLIPOPROTEIN J | Author keyword | 24 | 91% | 1% | 10 |
6 | SULFATED GLYCOPROTEIN 2 | Author keyword | 21 | 73% | 1% | 16 |
7 | SEZ BIOCHIM BIOCHIM CLIN BIOCHIM ESERCIZIO FIS | Address | 21 | 90% | 1% | 9 |
8 | SP 40 40 | Author keyword | 18 | 89% | 1% | 8 |
9 | CUSTIRSEN | Author keyword | 11 | 69% | 1% | 9 |
10 | OGX 011 | Author keyword | 11 | 78% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CLUSTERIN | 288 | 60% | 29% | 311 | Search CLUSTERIN | Search CLUSTERIN |
2 | ELASTOFIBROMA | 114 | 88% | 5% | 53 | Search ELASTOFIBROMA | Search ELASTOFIBROMA |
3 | ELASTOFIBROMA DORSI | 59 | 90% | 2% | 26 | Search ELASTOFIBROMA+DORSI | Search ELASTOFIBROMA+DORSI |
4 | APOLIPOPROTEIN J | 28 | 53% | 3% | 37 | Search APOLIPOPROTEIN+J | Search APOLIPOPROTEIN+J |
5 | CLUSTERIN APOLIPOPROTEIN J | 24 | 91% | 1% | 10 | Search CLUSTERIN+APOLIPOPROTEIN+J | Search CLUSTERIN+APOLIPOPROTEIN+J |
6 | SULFATED GLYCOPROTEIN 2 | 21 | 73% | 1% | 16 | Search SULFATED+GLYCOPROTEIN+2 | Search SULFATED+GLYCOPROTEIN+2 |
7 | SP 40 40 | 18 | 89% | 1% | 8 | Search SP+40+40 | Search SP+40+40 |
8 | CUSTIRSEN | 11 | 69% | 1% | 9 | Search CUSTIRSEN | Search CUSTIRSEN |
9 | OGX 011 | 11 | 78% | 1% | 7 | Search OGX+011 | Search OGX+011 |
10 | APOJ | 9 | 55% | 1% | 12 | Search APOJ | Search APOJ |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SULFATED GLYCOPROTEIN 2 | 269 | 70% | 21% | 222 |
2 | TESTIS FLUID | 158 | 91% | 6% | 67 |
3 | CLUSTERIN APOLIPOPROTEIN J | 135 | 78% | 8% | 90 |
4 | APOLIPOPROTEIN J CLUSTERIN | 131 | 87% | 6% | 65 |
5 | APOLIPOPROTEIN J | 107 | 58% | 12% | 123 |
6 | PROTEIN CLUSTERIN | 73 | 96% | 2% | 23 |
7 | NUCLEAR CLUSTERIN | 72 | 91% | 3% | 30 |
8 | RETE TESTIS FLUID | 70 | 69% | 6% | 60 |
9 | SP 40 40 | 37 | 59% | 4% | 41 |
10 | SGP 2 | 33 | 100% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Targeting heat shock proteins in metastatic castration-resistant prostate cancer | 2015 | 4 | 97 | 32% |
Clusterin: a key player in cancer chemoresistance and its inhibition | 2014 | 8 | 72 | 90% |
Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer | 2006 | 189 | 47 | 85% |
Clusterin: A forgotten player in Alzheimer's disease | 2009 | 108 | 189 | 58% |
Elastofibroma dorsi management and outcomes: review of 16 cases | 2014 | 3 | 15 | 100% |
Clusterin and Chemoresistance | 2009 | 48 | 77 | 73% |
The clusterin paradigm in prostate and breast carcinogenesis | 2010 | 42 | 130 | 72% |
CLUSTERIN - PHYSIOLOGICAL AND PATHOPHYSIOLOGIC CONSIDERATIONS | 1995 | 284 | 106 | 79% |
Sensitivity and positive predictive value of magnetic resonance imaging in the diagnosis of elastofibroma dorsi: review of fourteen cases | 2013 | 6 | 18 | 94% |
CLUSTERIN - THE INTRIGUING GUISES OF A WIDELY EXPRESSED GLYCOPROTEIN | 1992 | 290 | 44 | 80% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SEZ BIOCHIM BIOCHIM CLIN BIOCHIM ESERCIZIO FIS | 21 | 90% | 0.8% | 9 |
2 | MOL CELLULAR AGING | 6 | 50% | 0.8% | 9 |
3 | MOL ST S PONSES | 6 | 35% | 1.2% | 13 |
4 | MOL CELLULAR AGEING | 5 | 60% | 0.6% | 6 |
5 | PROSTATE | 5 | 11% | 4.4% | 47 |
6 | PROGRAM MED SCI BK21 | 4 | 50% | 0.6% | 6 |
7 | PROGRAM MOL CELLULAR BASIS DIS | 4 | 75% | 0.3% | 3 |
8 | BK21 PROGRAM MED SCI | 4 | 46% | 0.6% | 6 |
9 | ONCOL HAEMATOL PULMONOL | 2 | 67% | 0.2% | 2 |
10 | CARDIOVASC BIOCHEM GRP | 2 | 43% | 0.3% | 3 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000010489 | BENIGN PROSTATIC HYPERPLASIA//PROSTATE CANCER//PROSTATE |
2 | 0.0000009659 | PARAOXONASE//PARAOXONASE 1//PON1 |
3 | 0.0000007573 | ALZHEIMERS DISEASE//AMYLOID PRECURSOR PROTEIN//BETA AMYLOID |
4 | 0.0000007570 | TESTIS//SERTOLI CELLS//SPERMATOGENESIS |
5 | 0.0000006498 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
6 | 0.0000006217 | TRAIL//SURVIVIN//BCL 2 |
7 | 0.0000005378 | REELIN//DAB1//VLDLR |
8 | 0.0000004706 | ANDROLOGY//SPERMATOZOA//ACROSOME REACTION |
9 | 0.0000004701 | HSP90//CHAPERONIN//HEAT SHOCK PROTEIN |
10 | 0.0000004553 | EPITHELIAL MESENCHYMAL TRANSITION//EMT//SNAIL |